ACE2 and COVID-19: To determine whether TLR4-mediated ACE2 surface translocation in myeloid populations is also associated with COVID-19 severity, we treated peripheral blood cells from the same patient cohorts ex vivo with LPS for 4 h (Fig. 5a).